关注
John F Toso
John F Toso
Head, Translational Medicine, GSK
在 gsk.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma
JF Toso, VJ Gill, P Hwu, FM Marincola, NP Restifo, DJ Schwartzentruber, ...
Journal of clinical oncology 20 (1), 142-152, 2002
8972002
C-reactive protein in patients with COPD, control smokers and non-smokers
VM Pinto-Plata, H Müllerova, JF Toso, M Feudjo-Tepie, JB Soriano, ...
Thorax 61 (1), 23-28, 2006
7162006
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
V Pinto-Plata, J Toso, K Lee, D Park, J Bilello, H Mullerova, MM De Souza, ...
Thorax 62 (7), 595-601, 2007
2622007
CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection.
JJ Ferbas, JF Toso, AJ Logar, JS Navratil, CR Rinaldo Jr
Journal of immunology (Baltimore, Md.: 1950) 152 (9), 4649-4662, 1994
1881994
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck
S Yasumura, H Hirabayashi, DR Schwartz, JF Toso, JT Johnson, ...
Cancer research 53 (6), 1461-1468, 1993
1271993
Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors
N Chinnasamy, D Chinnasamy, JF Toso, R Lapointe, F Candotti, ...
Human gene therapy 11 (13), 1901-1909, 2000
1082000
Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen‐specific T lymphocytes
R Lapointe, JF Toso, C Butts, HA Young, P Hwu
European journal of immunology 30 (11), 3291-3298, 2000
1062000
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
S Srivastava, D Pelloso, H Feng, L Voiles, D Lewis, Z Haskova, ...
Cancer immunology, immunotherapy 62, 1073-1082, 2013
882013
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation
JF Toso, C Oei, F Oshidari, J Tartaglia, E Paoletti, HK Lyerly, S Talib, ...
Cancer research 56 (1), 16-20, 1996
811996
Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti–Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for …
G Ferrari, C Berend, J Ottinger, R Dodge, J Bartlett, J Toso, D Moody, ...
Blood, The Journal of the American Society of Hematology 90 (6), 2406-2416, 1997
691997
Chemoimmunotherapy using pegylated liposomal doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation study
F Simpkins, A Flores, C Chu, JS Berek, J Lucci III, S Murray, J Bauman, ...
Cancer immunology research 1 (3), 168-178, 2013
542013
Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo …
EH Choy, M Bendit, D McAleer, F Liu, M Feeney, S Brett, S Zamuner, ...
Arthritis research & therapy 15, 1-10, 2013
502013
Oligoclonal CD8 Lymphocytes from Persons with Asymptomatic Human Immunodeficiency Virus (HIV) Type 1 Infection Inhibit DIV-1 Replication
JF Toso, CH Chen, JR Mohr, L Piglia, C Dei, G Ferrari, ML Greenberg, ...
Journal of Infectious Diseases 172 (4), 964-973, 1995
481995
A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma
MJ Robertson, J Kline, H Struemper, KM Koch, JW Bauman, OS Gardner, ...
Journal of Immunotherapy 36 (6), 331-341, 2013
462013
Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters
V Pinto-Plata, J Toso, K Lee, J Bilello, H Mullerova, M De Souza, ...
Proceedings of the American Thoracic Society 3 (6), 465-466, 2006
302006
Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus
G Rappocciolo, JF Toso, DJ Torpey 3rd, P Gupta, CR Rinaldo Jr
Journal of clinical microbiology 27 (1), 41-48, 1989
301989
Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia
Z Haskova, MN Whitacre, KA Dede, JM Lee, SH Trulli, M Ciucci, JF Toso, ...
British journal of haematology 156 (3), 402-404, 2012
82012
CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells
JF Toso, R Lapointe, P Hwu
Journal of immunological methods 259 (1-2), 181-190, 2002
72002
A phase I, dose escalation trial to assess the safety and biological activity of recombinant human interleukin-18 (SB-485232) in combination with pegylated liposomal …
F Simpkins, AM Flores, C Chu, JA Lucci, JS Berek, G Coukos, ...
Journal of Clinical Oncology 30 (15_suppl), 5065-5065, 2012
52012
A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ B-cell non-Hodgkin's lymphoma
MJ Robertson, J Kline, J Bauman, O Gardner, Z Jonak, KM Koch, ...
Journal of Clinical Oncology 27 (15_suppl), 8566-8566, 2009
42009
系统目前无法执行此操作,请稍后再试。
文章 1–20